CureVac (CVAC) News Today $3.30 +0.02 (+0.61%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$3.31 +0.01 (+0.30%) As of 02/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period CureVac (NASDAQ:CVAC) Trading Down 6.1% - Time to Sell?CureVac (NASDAQ:CVAC) Shares Down 6.1% - Here's WhyFebruary 20 at 5:14 PM | marketbeat.comIs CureVac N.V. (CVAC) the Best Get Rich Fast Stock to Buy Now?February 20 at 10:43 AM | msn.comEQS-News: CureVac Earns Repeat Recognition by LexisNexis® as One of the World’s Top InnovatorsFebruary 19 at 9:52 AM | markets.businessinsider.comCureVac Earns Repeat Recognition by LexisNexis as One of the World's Top InnovatorsFebruary 18, 2025 | finanznachrichten.deCureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top InnovatorsFebruary 18, 2025 | finance.yahoo.comCureVac's SWOT analysis: mRNA pioneer's stock faces pivotal year in vaccine raceFebruary 17, 2025 | msn.comCureVac's (CVAC) Market Outperform Rating Reiterated at JMP SecuritiesFebruary 17, 2025 | americanbankingnews.comCureVac (NASDAQ:CVAC) Earns Market Outperform Rating from JMP SecuritiesJMP Securities reiterated a "market outperform" rating and set a $16.00 target price on shares of CureVac in a research note on Friday.February 15, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Gap Up - What's Next?CureVac (NASDAQ:CVAC) Shares Gap Up - Still a Buy?February 10, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Trading Down 5.8% - Here's WhyCureVac (NASDAQ:CVAC) Stock Price Down 5.8% - Here's What HappenedFebruary 3, 2025 | marketbeat.comFY2025 EPS Estimates for CureVac Raised by Leerink PartnrsCureVac (NASDAQ:CVAC - Free Report) - Analysts at Leerink Partnrs boosted their FY2025 EPS estimates for CureVac in a note issued to investors on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earnings per share of ($0.54) for the year, upJanuary 24, 2025 | marketbeat.comCompanies Like CureVac (NASDAQ:CVAC) Are In A Position To Invest In GrowthJanuary 23, 2025 | finance.yahoo.comCureVac (NASDAQ:CVAC) Stock Price Down 3.7% - What's Next?CureVac (NASDAQ:CVAC) Shares Down 3.7% - Should You Sell?January 22, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Trading 4.7% Higher - Here's What HappenedCureVac (NASDAQ:CVAC) Stock Price Up 4.7% - Still a Buy?January 16, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Up 5.7% - What's Next?CureVac (NASDAQ:CVAC) Stock Price Up 5.7% - Here's WhyJanuary 10, 2025 | marketbeat.comWhy CureVac (CVAC) Shares Are VolatileJanuary 10, 2025 | benzinga.comCureVac: Latest GBM Data Bodes Well For Next Program Check PointJanuary 8, 2025 | seekingalpha.comWhy CureVac (CVAC) Stock Is MovingJanuary 8, 2025 | benzinga.comCureVac (NASDAQ:CVAC) Shares Gap Down - Here's What HappenedCureVac (NASDAQ:CVAC) Shares Gap Down - Here's What HappenedJanuary 8, 2025 | marketbeat.comArbutus could benefit from Big Pharma bird flu vaccines: JefferiesJanuary 8, 2025 | msn.comCureVac (NASDAQ:CVAC) Sees Unusually-High Trading Volume - What's Next?CureVac (NASDAQ:CVAC) Sees Unusually-High Trading Volume - Should You Buy?January 7, 2025 | marketbeat.comModerna stock gains on rising flu casesJanuary 7, 2025 | in.investing.comCureVac (NASDAQ:CVAC) Shares Gap Up - Here's WhyCureVac (NASDAQ:CVAC) Shares Gap Up - Time to Buy?January 6, 2025 | marketbeat.comWhy CureVac (CVAC) Stock Is RisingJanuary 6, 2025 | benzinga.comVaccine stocks gain amid uptick in flu, COVID-19, RSVJanuary 6, 2025 | msn.comCureVac (NASDAQ:CVAC) Short Interest UpdateCureVac (NASDAQ:CVAC - Get Free Report) was the target of a large decrease in short interest in the month of December. As of December 15th, there was short interest totalling 3,940,000 shares, a decrease of 6.4% from the November 30th total of 4,210,000 shares. Approximately 4.2% of the company's shares are sold short. Based on an average daily trading volume, of 508,300 shares, the short-interest ratio is presently 7.8 days.December 31, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Trading Up 3.6% - Here's What HappenedCureVac (NASDAQ:CVAC) Shares Up 3.6% - Still a Buy?December 27, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Gap Down - Should You Sell?CureVac (NASDAQ:CVAC) Shares Gap Down - Here's WhyDecember 20, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Trading Down 5.5% - Time to Sell?CureVac (NASDAQ:CVAC) Shares Down 5.5% - Time to Sell?December 17, 2024 | marketbeat.com2 Small-Cap Stocks Set to Shine in a Bull MarketSmall-cap growth-orientated stocks like HTCR and CVAC often outperform during bullish markets due to their sensitivity to improving economic conditions.December 16, 2024 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Sold by Point72 Asset Management L.P.Point72 Asset Management L.P. cut its stake in CureVac (NASDAQ:CVAC - Free Report) by 67.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 780,005 shares of the company's stock after selling 1,642,723 shares durDecember 10, 2024 | marketbeat.comIs CureVac N.V. (CVAC) the Best German Stock to Buy Now?November 20, 2024 | msn.comLeerink Partners Sticks to Their Hold Rating for CureVac (CVAC)November 15, 2024 | markets.businessinsider.comCureVac: Strong Financial Position and Promising Pipeline Justify Buy RatingNovember 15, 2024 | markets.businessinsider.comCureVac Reports Significant Revenue Growth Amid Strategic RestructuringNovember 13, 2024 | markets.businessinsider.comCureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...November 13, 2024 | uk.finance.yahoo.comCureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...November 13, 2024 | uk.finance.yahoo.comCureVac reports Q3 revenue EUR 493.9M vs. EUR 16.5M last yearNovember 13, 2024 | markets.businessinsider.comCureVac Reports Surging Revenues and Profit GrowthNovember 13, 2024 | markets.businessinsider.comCureVac N.V. (CVAC) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comCureVac (CVAC) to Release Earnings on TuesdayCureVac (NASDAQ:CVAC) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports.November 8, 2024 | marketbeat.comCureVac presents new, updated data at mRNA Health ConferenceNovember 6, 2024 | markets.businessinsider.comCureVac Appoints New CFO to Drive GrowthNovember 5, 2024 | markets.businessinsider.comCureVac’s Latest mRNA Advances Spark Investor InterestNovember 5, 2024 | markets.businessinsider.comCureVac (NASDAQ:CVAC) Shares Up 3.9% - Should You Buy?CureVac (NASDAQ:CVAC) Stock Price Up 3.9% - Still a Buy?October 29, 2024 | marketbeat.comEQS-News: CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual MeetingOctober 28, 2024 | markets.businessinsider.comCureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual MeetingOctober 28, 2024 | finance.yahoo.comCureVac (NASDAQ:CVAC) Shares Gap Up - Should You Buy?CureVac (NASDAQ:CVAC) Shares Gap Up - Should You Buy?October 9, 2024 | marketbeat.comCureVac: Back To Square OneOctober 8, 2024 | seekingalpha.comPfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patentsOctober 8, 2024 | reuters.com Get CureVac News Delivered to You Automatically Sign up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter. Email Address CVAC Media Mentions By Week CVAC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVAC News Sentiment▼0.520.60▲Average Medical News Sentiment CVAC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVAC Articles This Week▼83▲CVAC Articles Average Week Get CureVac News Delivered to You Automatically Sign up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRNX News Today ZLAB News Today DNLI News Today XENE News Today MOR News Today TWST News Today VCEL News Today CPRX News Today MLTX News Today MRUS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CVAC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CureVac Please log in to your account or sign up in order to add this asset to your watchlist. Share CureVac With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CVAC Stock Alerts